HLN / Haleon down as sales and earnings marginally undershoot - maintains full-year outlook

Haleon PLC (LSE:HLN, NYSE:HLN)'s stock took a 2.6% hit in early trading, erasing roughly £800 million in market value, following the company's third- more_horizontal

Consumer healthcare company Haleon posted higher third-quarter revenue and stuck by its full-year forecasts on Thursday, helped by price hikes and res more_horizontal

Sanofi (FRA: SNW), the giant healthcare company, is considering spinning off its consumer health business. In a statement, the management said it was more_horizontal

Haleon's share price has slumped, but its performance is relatively better compared to its consumer staples peers and the recent listing Kenvue. HLN h more_horizontal

The FTSE 100 healthcare firm said that revenues increased 10.6% in the first half, while pre-tax profit increased 11.1% year on year. more_horizontal

British consumer healthcare giant, Haleon PLC (LSE:HLN, NYSE:HLN), has upgraded its full-year sales and earnings guidance for 2023, reflecting a solid more_horizontal

Haleon on Wednesday raised its forecast for annual organic revenue growth as the consumer healthcare company is confident that demand for its oral and more_horizontal

Defence contractor BAE Systems PLC (LSE:BA.) reports half-year numbers fresh from winning a host of contracts, including from the UK, Israel and Sa more_horizontal